A Review of Current and Emerging Treatment Options for Myelodysplastic Syndromes

In this comprehensive program centered on an in-person and online live CCO symposium at ASH 2021 experts discuss recent developments in the management of myelodysplastic syndromes. Review their insights in an on-demand webcast and downloadable slides from the symposium.

Share

Program Content

Managing Higher-risk and RR MDS
Latest Guidance on the Treatment of Higher-Risk MDS and Managing Relapsed/Refractory MDS
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 10, 2021

Expires: December 09, 2022

View Activity
Lower-risk MDS Therapy
Therapeutic Approaches for the Treatment of Lower-Risk MDS and Anemia Management
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 10, 2021

Expires: December 09, 2022

View Activity
Immuno-oncology for MDS
Novel Therapeutic Strategies for MDS Focused on the Stroma and Immuno-oncology
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 10, 2021

Expires: December 09, 2022

View Activity
<em>ExpressPoints</em>: Tx for MDS
ExpressPoints
A Review of Current and Emerging Treatment Options for Myelodysplastic Syndromes
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 23, 2021

Expires: December 22, 2022

View Activity
Tx Options for MDS
A Review of Current and Emerging Treatment Options for Myelodysplastic Syndromes
Multimedia
Congratulations: You achieved a completion on 04/09/2022

Released: January 13, 2022

Expires: January 12, 2023

View Activity

Faculty

cover img faculity

Michael R. Savona, MD, FACP

Director of Leukemia Research
Senior Investigator, Hematologic Malignancies Research and Drug Development
Sarah Cannon Research Institute
Sarah Cannon Center for Blood Cancers
Tennessee Oncology
Nashville, Tennessee

cover img faculity

Jacqueline S. Garcia, MD

Assistant Professor, Medicine
Harvard Medical School
Adult Leukemia Program
Department of Medical Oncology
Dana-Farber Cancer Institute
Boston, Massachusetts

cover img faculity

Amer Zeidan, MBBS, MPH

Associate Professor, Internal Medicine
Hematology
Leader, Leukemia and Myeloid Disease Aligned Research Team (DART)
Director, Hematology Early Therapeutics Research
Yale Cancer Center and Smilow Cancer Hospital
Yale University School of Medicine
New Haven, Connecticut

Provided by

ProCE Banner

Supporters

Supported by educational grants from

AbbVie Inc.

Gamida Cell Ltd

Geron

Gilead Sciences, Inc.

Karyopharm Therapeutics Inc.

Takeda Pharma USA Inc Takeda Onc Co